Physician profile
April Ward
NPI 1649597345
$1,732.02
in general payments reported to CMS, 2019-2025
11 companies · $644 in 2025
The $644 reported for 2025 was more than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $36.00 · 2023: $350 · 2024: $702 · 2025: $644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,696.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,696.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $602.91 | 2023-2025 | Abilify Asimtufii, Rexulti, Abilify Maintena |
| Janssen Pharmaceuticals, INC | $251.05 | 2023-2025 | Invega Sustenna, Invega, Spravato |
| Abbvie INC. | $196.60 | 2024-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $194.10 | 2022-2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $149.80 | 2023-2025 | Fanapt, Hetlioz |
| Otsuka America Pharmaceutical, INC. | $120.74 | 2023-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Neurocrine Biosciences, INC. | $113.61 | 2024-2025 | Ingrezza |
| Axsome Therapeutics, INC. | $36.42 | 2025 | Auvelity |
| Alkermes, INC. | $30.98 | 2025 | Aristada, Lybalvi |
| Janssen Biotech, INC. | $19.90 | 2023 | |
| Laborie Medical Technologies Corp. | $15.91 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw April Ward listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.